A Randomized Controlled Trial Evaluating Whether Pre-operative Trinase Reduces Post-operative Pain in Patients With Symptomatic Irreversible Pulpitis Compared to Placebo, Using VAS Scores and Analgesic Intake Over 48 Hours.

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18-50
SponsorFayoum University

About this trial

This study aims to determine whether Trinase, an enzyme-based anti-inflammatory medication, can reduce pain after root canal treatment in patients with symptomatic irreversible pulpitis. A total of 182 male patients aged 18 to 50 years who present with moderate to severe tooth pain will be randomly assigned to receive either a Trinase tablet or a placebo 30 minutes before treatment. All root canal procedures will be performed in a single visit using standard endodontic techniques.

Pain levels will be measured on a Visual Analogue Scale (VAS) before treatment and at 6, 12, 24, and 48 hours after treatment. Patients will also record the number of pain-relief tablets they take during the first 48 hours. The goal of the study is to see whether Trinase can lower post-operative pain and reduce the need for analgesic medication compared with placebo. This information may help improve pain management for patients undergoing root canal therapy.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Systemically healthy male patients (ASA I or II)

Aged 18 to 50 years

Presenting with symptomatic irreversible pulpitis in a restorable mandibular molar

Preoperative moderate to severe pain (VAS ≥45 mm)

Disqualifiers

History of allergy or intolerance to Trinase or any of its components (trypsin, bromelain, rutin)

Vertical root fracture

External or internal root resorption

Periodontal pocket depth >5 mm

Trial design

Design model

Parallel

Treatments tested in this trial

  • Trinase

    Drug

    One tablet of Trinase (proteolytic enzyme combination: trypsin, bromelain, and rutin) administered orally 30 minutes prior to root canal treatment. Used as premedication to reduce postoperative pain and inflammation.

  • placebo capsule

    Drug

    One identical-appearing placebo tablet administered orally 30 minutes prior to root canal treatment. Used as control.

Treatment groups

182 Participants
are divided into 2 treatment groups
Group A: Trinase groupExperimental treatment 1 intervention
Group B: Placebo groupPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Post-operative pain intensity assessed by Visual Analogue Scale (VAS)

Pain intensity recorded by patients on a 10-cm Visual Analogue Scale (VAS) where 0 = no pain and 100 = pain as bad as it could be. Scores categorized as: no pain (0-4 mm), mild (5-44 mm), moderate (45-74 mm), severe (75-100 mm). Measured at baseline and post-operatively.

Time frame
6, 12, 24, and 48 hours after root canal treatment

Secondary outcomes

1

Number of analgesic tablets consumed within 48 hours post-treatment

Total number of rescue analgesic tablets (Trinase) taken by patients within 48 hours after root canal treatment, as recorded on provided charts during follow-up.

Time frame
Within 48 hours post-treatment

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.